Express Scripts Announces New Recommendations Tackling High Drug Prices
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall St mixed as investors assess softer jobs data
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil falls to four-month low as US, Iran conclude talks in Doha
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Meta Platforms stock surges 8% on cloud business plans
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Wall Street ends choppy session lower as tech shares drop
Formulary Update Positive for Mylan (MYL) - Evercore ISI
August 7, 2018 10:05 AM EDTExpress Scripts' (NASDAQ: ESRX) formulary update today is positive for Mylan's (NYSE: MYL) HIV drug, Evercore ISI analsyt Umer Raffat notes.
"Today, ESRX issued a formulary update where they are now replacing Atripla with SYMFI.... More
